Skip to main content
Back
Watch Compare

Processa Pharmaceuticals, Inc.

Data quality: 83%
PCSA
Nasdaq Manufacturing Chemicals
$2.97
▼ $0.05 (-1.66%)
Mkt Cap: 7.90 M
Price
$2.97
Mkt Cap
7.90 M
Day Range
$2.86 — $3.14
52-Week Range
$1.76 — $19.63
Volume
45,822
Open $2.96
50D / 200D Avg
$2.57
15.71% above
50D / 200D Avg
$5.05
41.21% below

Quick Summary

Key Takeaways

Negative free cash flow of -11.39 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-227.18%
Below sector avg (-53.41%)
ROIC-185.10%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio3.76
Interest CoverageN/A

Valuation

PE (TTM)
-0.58
Above sector avg (-1.48)
P/B Ratio1.35
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.6 -1.5
P/B 1.4 1.6
ROE % -227.2 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -13.56 M
ROE -227.18% ROA -172.06%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -11.39 M
ROIC -185.10% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.76
Interest Coverage N/A Asset Turnover N/A
Working Capital 4.84 M Tangible Book Value 5.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.58 Forward P/E N/A
P/B Ratio 1.35 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -144.11%
Market Cap 7.90 M Enterprise Value 1.59 M
Per Share
EPS (Diluted TTM) -10.36 Revenue / Share N/A
FCF / Share -4.28 OCF / Share -4.28
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 83.94%
SBC-Adj. FCF -12.27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0.0 0.0
Net Income -13.56 M -11.85 M -11.12 M -27.42 M -11.43 M
EPS (Diluted) -10.36 -3.87 -8.48 — —
Gross Profit — — — — —
Operating Income -13.99 M -12.05 M -11.46 M -27.53 M -12.13 M
EBITDA — — — — —
R&D Expenses — — 5.80 M 11.49 M 6.88 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 362.0
Income Tax — — — -530,611.0 -530,611.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7.81 M 3.23 M 5.79 M 8.62 M 26.46 M
Total Liabilities 2.24 M 1.53 M 797,484.0 1.15 M 978,405.0
Shareholders' Equity 5.58 M 1.70 M 4.99 M 7.47 M 25.49 M
Total Debt — — — — —
Cash & Equivalents 5.54 M 1.19 M 4.71 M 6.50 M 16.50 M
Current Assets 5.67 M 1.87 M 5.63 M 8.39 M 18.33 M
Current Liabilities 2.24 M 1.53 M 730,579.0 998,556.0 971,020.0